COLL
Collegium Pharmaceutical Inc
NASDAQ · Pharmaceuticals
$47.61
+0.69 (+1.47%)
Open$47.48
Previous Close$46.92
Day High$48.05
Day Low$47.05
52W High$50.79
52W Low$23.23
Volume—
Avg Volume389.0K
Market Cap1.50B
P/E Ratio25.75
EPS$1.49
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+1.1% upside
Current
$47.61
$47.61
Target
$48.15
$48.15
$33.48
$48.15 avg
$61.72
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 493.78M | 375.13M | 517.48M |
| Net Income | 54.11M | 36.99M | 73.22M |
| Profit Margin | 11.0% | 10.4% | 14.2% |
| EBITDA | 127.01M | 91.67M | 136.97M |
| Free Cash Flow | — | — | 107.99M |
| Rev Growth | +31.6% | +31.6% | +4.0% |
| Debt/Equity | 3.73 | 3.73 | 0.44 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |